Investment Management Associates Inc. ADV Sells 775 Shares of Solventum Co. (NYSE:SOLV)

Investment Management Associates Inc. ADV trimmed its holdings in Solventum Co. (NYSE:SOLV) by 0.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 114,123 shares of the company’s stock after selling 775 shares during the quarter. Solventum comprises about 3.3% of Investment Management Associates Inc. ADV’s investment portfolio, making the stock its 14th biggest holding. Investment Management Associates Inc. ADV owned about 0.07% of Solventum worth $7,539,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the business. Worldquant Millennium Advisors LLC increased its holdings in shares of Solventum by 373.6% during the third quarter. Worldquant Millennium Advisors LLC now owns 47,665 shares of the company’s stock valued at $3,323,000 after acquiring an additional 37,600 shares in the last quarter. Harbor Capital Advisors Inc. grew its position in Solventum by 24.8% during the 4th quarter. Harbor Capital Advisors Inc. now owns 46,965 shares of the company’s stock valued at $3,103,000 after purchasing an additional 9,333 shares during the last quarter. The Manufacturers Life Insurance Company increased its stake in Solventum by 37.4% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 117,853 shares of the company’s stock valued at $8,217,000 after purchasing an additional 32,051 shares in the last quarter. State Street Corp raised its holdings in Solventum by 3.1% in the third quarter. State Street Corp now owns 6,107,550 shares of the company’s stock worth $425,818,000 after buying an additional 185,938 shares during the last quarter. Finally, Forsta AP Fonden bought a new position in shares of Solventum in the fourth quarter worth approximately $1,876,000.

Solventum Stock Performance

SOLV stock opened at $74.44 on Friday. The business’s 50-day moving average is $71.07 and its two-hundred day moving average is $68.95. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $96.05. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Morgan Stanley raised their price target on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. Mizuho started coverage on Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 target price for the company. Finally, Piper Sandler boosted their price target on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $68.29.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.